Nothing is perfect: the safety issues of integrase inhibitor regimens-Reference-Cited by-同舟云学术

Nothing is perfect: the safety issues of integrase inhibitor regimens

Published:2020-05-22 Issue:6 Volume:19 Page:683-694
ISSN:1474-0338
Container-title:Expert Opinion on Drug Safety
language:en
Short-container-title:Expert Opinion on Drug Safety

Author:

Scévola Sofía¹,Tiraboschi Juan Manuel¹,Podzamczer Daniel

Affiliation:

1. HIV and STI Unit, Infectious Disease Service, Hospital Universitari de Bellvitge-IDIBELL, Universitat de Barcelona, L’Hospitalet de Llobregat, Barcelona, Spain

Publisher

Informa UK Limited

Subject

Pharmacology (medical),General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14740338.2020.1764531

Reference74 articles.

1. Prevention of HIV-1 Infection with Early Antiretroviral Therapy

2. Closing the Gap: Increases in Life Expectancy among Treated HIV-Positive Individuals in the United States and Canada

3. Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus Infection

4. Gesida: Plan nacional sobre el sida respecto al tratamiento antirretroviral en adultos infectados por el virus de la inmunodeficiencia humana; 2019 [cited 2019 Dec 20]. Available from: http://gesida-seimc.org/category/guias-clinicas/

5. AIDSinfo: Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents with HIV; 2019 [cited 2019 Dec 20]. Available from: https://aidsinfo.nih.gov/guidelines

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adherence to antiretroviral therapy and viral suppression: Analysis of three periods between 2011 and 2017 at an HIV-AIDS center, Brazil;Frontiers in Pharmacology;2023-03-31

2. Body mass index and quality of life in people living with HIV;AIDS Care;2023-03-13

3. Effectiveness of integrase strand transfer inhibitors in HIV‐infected treatment‐experienced individuals across Europe;HIV Medicine;2022-02-24

4. Hypersensitivity reactions, hepatotoxicity, and other discontinuations in persons receiving integrase strand transfer inhibitors: results from the EuroSIDA study;HIV RES CLIN PRACT;2021

5. Darunavir/cobicistat/emtricitabine/tenofovir alafenamide versus dolutegravir /abacavir/lamivudine in antiretroviral-naïve adults (SYMTRI): a multicenter randomized open-label study (PReEC/RIS-57);Open Forum Infectious Diseases;2021-11-25